Get started
Author

Kristen Ricchetti-Masterson

Observed names: K L Ricchetti-Masterson, K. L. Ricchetti-Masterson, K. Ricchetti-Masterson, Kristen L Ricchetti-Masterson, Ricchetti-Masterson Kristen, Ricchetti-Masterson, Kristen
ORCID: 0000-0001-6970-7045
Observed ORCID: 0000-0001-6970-7045
OpenAlex ID: A5026670274
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review
2021 · Bernhard J. Steinhoff, Pavel Klein, et al. · Epilepsy & Behavior · 119
PDF
Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review
2023 · James D. Berry, Marie Blanchard, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 40
Epidemiology of hyperhidrosis in 2 population-based health care databases
2017 · Kristen Ricchetti-Masterson, J. Morel Symons, et al. · Journal of the American Academy of Dermatology · 26
Social Factors as Modifiers of Hurricane Irene Evacuation Behavior in Beaufort County, NC
2013 · Kristen Ricchetti-Masterson, Jennifer Horney · PLoS Currents · 20
Fueling the Public Health Workforce Pipeline Through Student Surge Capacity Response Teams
2013 · J. A. Horney, M. K. Davis, et al. · Journal of Community Health · 19
Resident perception of disaster recovery planning priorities
2016 · Jennifer Horney, Matt C. Simon, et al. · International Journal of Disaster Resilience in the Built Environment · 13
Exploring Methods to Measure the Prevalence of Ménière's Disease in the US Clinformatics™ Database, 2010-2012
2016 · Kristen Ricchetti-Masterson, Molly Aldridge, et al. · Audiology and Neurotology · 6
Clinical and Economic Outcomes of Intravenous Brivaracetam Compared With Levetiracetam for the Treatment of Seizures in United States Hospitals
2021 · Silky Beaty, Ning A. Rosenthal, et al. · Frontiers in Neurology · 3
PDF
The natural history of Becker muscular dystrophy: A systematic literature review
2026 · Alexis T Mickle, Karissa M Johnston, et al. · Journal of Neuromuscular Diseases · 2
Current Challenges of Using Patient-Level Claims and Electronic Health Record Data for the Longitudinal Evaluation of Duchenne Muscular Dystrophy Outcomes
2024 · Katherine L. Gooch, Ivana Audhya, et al. · Advances in Therapy · 2
Epidemiology and injectable antiseizure medication treatment patterns of seizure patients treated in United States hospitals
2022 · Silky Beaty, Ning Rosenthal, et al. · Frontiers in Neurology · 2
391P Agreement and accuracy of ambulatory definitions in Duchenne muscular dystrophy (DMD): a cross-sectional analysis
2024 · A. Macedo, J. Logan, et al. · Neuromuscular Disorders · 1
2315 12-month effectiveness and tolerability of brivaracetam in the real-world: interim analysis of the international, multicenter non-interventional EXPERIENCE study
2022 · Vicente Villanueva, Wendyl J D’Souza, et al. · Abstracts
PDF
12-month effectiveness and tolerability of brivaracetam in the real-world: interim analysis of the international, non-interventional EXPERIENCE study (P13-8.002)
2022 · Vicente Villanueva, Wendyl D’Souza, et al. · Neurology
Outcomes of Intravenous Use of Brivaracetam and Levetiracetam for the Treatment of Seizures in US Hospitals (1724)
2021 · Silky Beaty, Ning Rosenthal, et al. · Neurology
A systematic review of behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate in real-world studies (1711)
2021 · Bernhard J. Steinhoff, Pavel Klein, et al. · Neurology
Intravenous Antiseizure Medication Utilization Patterns Among Seizure Patients Treated in US Hospitals: a Database Analysis (1719)
2021 · Silky Beaty, Ning Rosenthal, et al. · Neurology
P5-S5.01 Factors associated with stated willingness to accept expedited partner therapy from sex partners, NYC, 2007–2008
2011 · D Sanchez, K L Ricchetti-Masterson, et al. · Sexually Transmitted Infections
PDF
Works count: 19
Citation count: 252
H-index: 6
I10-index: 6
Year
Topic
Type